Literature DB >> 433633

The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale.

P Bech, T G Bolwig, P Kramp, O J Rafaelsen.   

Abstract

In a study of 18 patients with manic symptomatology and 31 patients with melancholic symptomatology the Bech-Rafaelsen Mania Scale (BRMS) and the Hamilton Depression Scale (HDS) have been compared. The results showed that the inter-observer reliability of the BRMS was adequate compared with the HDS. Both scales are constructed for assessing the severity of manic or melancholic states, and no difference was found in the total BRMS or HDS score between the various diagnostic groups, when the patients were classified by an index of the course and symptomatology otive disorder, using the Multi-axial Classificetion System for Affective Disorders (MULTI-CLAD). The homogeneity of the BRMS seemed more adequate than that of the HDS, when each item was correlated to the corresponding total score. Although the homogeneity of the BRMS needs to be evaluated by other statistical models than correlation analysis, our results seem to indicate that the improvement in assessing manic-melancholic states quantitatively is a matter of redefining items or incorporating new items in the melancholic rather than the manic part of these rating scales.

Entities:  

Mesh:

Year:  1979        PMID: 433633     DOI: 10.1111/j.1600-0447.1979.tb04484.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  63 in total

1.  Psychotherapy for Bipolar Disorder in Adults: A Review of the Evidence.

Authors:  Holly A Swartz; Joshua Swanson
Journal:  Focus (Am Psychiatr Publ)       Date:  2014

2.  Changes in regional cerebral blood flow demonstrated by 99mTc-HMPAO SPECT in euthymic bipolar patients.

Authors:  Atesci Figen Culha; Ozdel Osman; Yuksel Dogangün; Karadag Filiz; Kirac Suna; Oguzhanoglu Nalan Kalkan; Varma Gulfizar; Akdag Beyza
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04       Impact factor: 5.270

3.  Role of treatment alliance in the clinical management of bipolar disorder: stronger alliances prospectively predict fewer manic symptoms.

Authors:  Jennifer L Strauss; Sheri L Johnson
Journal:  Psychiatry Res       Date:  2006-10-31       Impact factor: 3.222

4.  Cerebrospinal fluid vasopressin in neurological and psychiatric disorders.

Authors:  P S Sørensen; A Gjerris; M Hammer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-01       Impact factor: 10.154

5.  Social rhythm disrupting events increase the risk of recurrence among individuals with bipolar disorder.

Authors:  Jessica C Levenson; Meredith L Wallace; Barbara P Anderson; David J Kupfer; Ellen Frank
Journal:  Bipolar Disord       Date:  2015-11-28       Impact factor: 6.744

6.  The role of interpersonal and social rhythm therapy in improving occupational functioning in patients with bipolar I disorder.

Authors:  Ellen Frank; Isabella Soreca; Holly A Swartz; Andrea M Fagiolini; Alan G Mallinger; Michael E Thase; Victoria J Grochocinski; Patricia R Houck; David J Kupfer
Journal:  Am J Psychiatry       Date:  2008-10-01       Impact factor: 18.112

7.  Altered hippocampal morphology in unmedicated patients with major depressive illness.

Authors:  Carrie E Bearden; Paul M Thompson; Christina Avedissian; Andrea D Klunder; Mark Nicoletti; Nicole Dierschke; Paolo Brambilla; Jair C Soares
Journal:  ASN Neuro       Date:  2009-11-10       Impact factor: 4.146

8.  Psychosocial correlates of subsyndromal symptoms and functioning of bipolar patients stabilized on prophylactic lithium.

Authors:  D Kumar; D Basu; P Kulhara; P Sharan
Journal:  Indian J Psychiatry       Date:  2001-07       Impact factor: 1.759

9.  Seasonality in affective disorders using SPAQ.

Authors:  Ajit Avasthi; Nitin Gupta; Pramanand Kulhara; Pratap Sharan; Gagandeep Singh; Rajinder Pal Kaur; Rajni Sharma
Journal:  Indian J Psychiatry       Date:  2003-07       Impact factor: 1.759

10.  Development of the treatment attitudes questionnaire in bipolar disorder.

Authors:  Sheri L Johnson; Daniel Fulford
Journal:  J Clin Psychol       Date:  2008-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.